DermTech, Inc.
NASDAQ:DMTK
0.094 (USD) • At close June 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 15.296 | 14.518 | 11.838 | 5.885 | 3.364 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 15.02 | 13.871 | 10.564 | 5.981 | 3.304 | 0.306 | 0 | 0 | 0 |
| Gross Profit
| 0.276 | 0.647 | 1.274 | -0.096 | 0.06 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.018 | 0.045 | 0.108 | -0.016 | 0.018 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 15.239 | 24.052 | 16.261 | 5.293 | 2.497 | 2.054 | 1.997 | 1.958 | 0.976 |
| General & Administrative Expenses
| 43.781 | 36.086 | 24.836 | 13.823 | 8.865 | 0 | 0 | 1.273 | 1.064 |
| Selling & Marketing Expenses
| 44.995 | 58.674 | 37.575 | 16.077 | 6.303 | 0 | 0 | 0.031 | 0.126 |
| SG&A
| 88.776 | 94.76 | 62.411 | 29.9 | 15.168 | 6.321 | 0.306 | 1.304 | 1.19 |
| Other Expenses
| 0 | 0 | 0 | 0 | -0.355 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 104.015 | 118.812 | 78.672 | 35.193 | 17.665 | 8.726 | 0.306 | 3.262 | 2.166 |
| Operating Income
| -103.739 | -118.165 | -77.398 | -35.289 | -17.605 | -0.306 | -0.306 | -3.262 | -2.166 |
| Operating Income Ratio
| -6.782 | -8.139 | -6.538 | -5.996 | -5.233 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.851 | 1.482 | -0.937 | -1.188 | -2.084 | 1.557 | 0.306 | -1.916 | -0.062 |
| Income Before Tax
| -100.888 | -116.683 | -78.335 | -36.477 | -19.689 | 0.944 | -0 | -5.178 | -2.228 |
| Income Before Tax Ratio
| -6.596 | -8.037 | -6.617 | -6.198 | -5.853 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -2.964 | -1.359 | -0.526 | 2.213 | -1.163 | 0 | 0 | 0 |
| Net Income
| -100.888 | -116.683 | -78.335 | -36.477 | -21.902 | 0.856 | -0 | -5.178 | -2.228 |
| Net Income Ratio
| -6.596 | -8.037 | -6.617 | -6.198 | -6.511 | 0 | 0 | 0 | 0 |
| EPS
| -3.09 | -3.88 | -2.71 | -2.05 | -3.13 | 0.36 | 0 | -1.1 | -0.65 |
| EPS Diluted
| -3.09 | -3.88 | -2.71 | -2.05 | -3.13 | 0.36 | 0 | -1.1 | -0.65 |
| EBITDA
| -97.893 | -113.846 | -74.014 | -35.289 | -17.96 | -0.261 | -0 | -3.243 | -2.112 |
| EBITDA Ratio
| -6.4 | -7.842 | -6.252 | -5.996 | -5.339 | 0 | 0 | 0 | 0 |